• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 TITANIUM DOME IMPLANTABLE PORT, GROSHONG SINGLE-LUMEN, 8F; PORT & CATHETER, IMPLANED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 TITANIUM DOME IMPLANTABLE PORT, GROSHONG SINGLE-LUMEN, 8F; PORT & CATHETER, IMPLANED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Model Number 0602850
Medical Device Problem Codes Fracture (1260); Difficult to Advance (2920); Migration (4003)
Health Effect - Clinical Code Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Date of Event 10/26/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
As the lot number for the device was provided, a review of the device history records is currently being performed.The device has not been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.(expiry date: 10/2023).
 
Event or Problem Description
It was reported through the litigation process that an implantable port was placed in a patient, the reason for placement was not given.Approximately 3 months after port placement, the device allegedly fractured and migrated to the patient's right ventricle.It was further reported that patient underwent heart surgery to remove the fractured catheter.The current status of the patient is unknown.
 
Event or Problem Description
It was reported through the litigation process that an implantable port was placed in a patient, the reason for placement was not given.Approximately three months after port placement, the device allegedly fractured and migrated to the patient's right ventricle.It was further reported that patient underwent heart surgery to remove the fractured catheter.The current status of the patient is unknown.
 
Additional Manufacturer Narrative
H10: manufacturing review: a complaint history review was performed.This is the third complaint reported for this lot number.Therefore, a device history record review was performed and the lot met all release criteria.Investigation summary: the sample was not returned for evaluation.One medical record was provided for review.The investigation is confirmed for catheter fracture, migration and difficult to insert wire as during deployment, after several attempts, it was able to pass a wire without any resistance into the superior vena cava right atrial junction.Post filter deployment, chest x-ray revealed that there was no evidence of pneumothorax or hematoma.Approximately three months later, the patient pretested for port removal.The port catheter fractured and ended up in the right ventricle and was retrieved successfully by interventional radiology.Subsequently under the guidance of fluoroscope, complete removal of the proximal fragment attached to port was accomplished.There was no bleeding.The port and complete fragment attached to port was removed.A definitive root cause could not be determined based upon available information.Labeling review: a review of product labeling documentation (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device not returned.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TITANIUM DOME IMPLANTABLE PORT, GROSHONG SINGLE-LUMEN, 8F
Common Device Name
PORT & CATHETER, IMPLANED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
MDR Report Key11444198
Report Number3006260740-2021-00753
Device Sequence Number19707299
Product Code LJT
UDI-Device Identifier00801741025754
UDI-Public(01)00801741025754
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
K880571
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Device Explanted Year2021
Reporter Type Manufacturer
Report Source consumer,health professional
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 06/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number0602850
Device Catalogue Number0602850
Device Lot NumberREDT0903
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 02/16/2021
Supplement Date Received by Manufacturer06/08/2021
Initial Report FDA Received Date03/09/2021
Supplement Report FDA Received Date06/10/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Weight70
-
-